NOTE 15. CREDIT FACILITY
As per December 31, 2016, ASMI is debt-free. ASMI may borrow under separate short-term lines of credit with banks under an unsecured €150 million standby credit facility with a consortium of banks.
Total short-term lines of credit amounted to €150 million at December 31, 2016. The amount outstanding at December 31, 2016 was nil, so the undrawn portion totaled €150 million. The undrawn portion represents the Company’s standby revolving credit facility of €150 million with a consortium of banks. The facility will be available through December 16, 2021, with an extension option for up to two years.
The credit facility of €150 million includes two financial covenants:
- minimum Consolidated tangible net worth; and
- Consolidated total net debt/total equity ratio.
These financial covenants are measured twice each year, at June 30 and December 31.
The minimum level of Consolidated tangible net worth for the year ended December 31, 2016 required was €450 million, the Consolidated tangible net worth as per that date was €1,101 million.
Consolidated tangible net worth is defined as the net assets, deducting any amount shown in respect of goodwill or other intangible assets (including any value arising from any valuation of ASMPT).
Total equity is defined as the aggregate of:
- the amounts paid up on the issued common shares;
- share capital in excess of par value;
- retained earnings;
- accumulated other comprehensive income and loss; and
- deducting any amount shown in respect of goodwill or other intangible assets .
The net debt/total equity ratio should not exceed 1.5. For the year ended December 31, 2016, net cash was €378 million and total equity amounted to €2,016 million. The Company is in compliance with these financial covenants as of December 31, 2016.
ASMI does not provide guarantees for borrowings of ASMPT and there are no guarantees from ASMPT to secure indebtedness of ASMI. Under the rules of the Stock Exchange of Hong Kong, ASMPT is precluded from providing loans and advances other than trade receivables in the normal course of business, to ASMI or its non-ASMPT subsidiaries.